Nusano has signed a multi-year supply agreement with Cellectar Biosciences to provide iodine-125 and actinium-225 critical for cancer therapies. This agreement enhances Cellectar’s clinical pipeline, securing isotope access needed for important clinical programs. It represents a significant step for Nusano as it strengthens its role in the radiopharmaceutical supply chain.
Company Information
Company
Nusano
Location
4669 W Lake Park Blvd
Valencia, New Mexico, United States
About
Nusano is a medical technology company that creates radioisotopes—tiny tracers used by doctors to diagnose and treat cancer and other diseases. Doctors use these tiny tracers like flashlights to light up areas inside the body. They can see how blood is flowing, how organs are functioning, even how cells are growing. Advanced medicines and treatment methods also use radioisotopes to target and eliminate cancer cells with precision.
ValenciaInformation TechnologyBiotechnologyHealth CareMedicalMedical Deviceresearch